Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics (Q45123845)

9 December 2017

Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics (English)

1 reference

9 December 2017

Ding AA

1

1 reference

PubMed ID

10465932

9 December 2017

Wu H

series ordinal

2

1 reference

9 December 2017

1 August 1999

1 reference

9 December 2017

20

1 reference

based on heuristic

inferred from page(s)

published in

Mathematical Biosciences

1 reference

9 December 2017

160

1 reference

9 December 2017

1

1 reference

9 December 2017

63-82

1 reference

PubMed ID

10465932

maintained by WikiProject

9 December 2017

WikiProject Mathematics

0 references

cites work

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

Viral dynamics in human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

Decay characteristics of HIV-1-infected compartments during combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

Population HIV-1 dynamics in vivo: applicable models and inferential tools for virological data from AIDS clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

Influence of delayed viral production on viral dynamics in HIV-1 infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

How frequently should viral load be monitored to evaluate antiretroviral therapies in AIDS clinical trials?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2899%2900021-8

10.1016/S0025-5564(99)00021-8

7 January 2021

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

10465932